The Trump Administration and Drug Policy

In light of the results of the November 8, 2016 election, the Drugs & the Law Committee invited the legal community and the public at large to join in a discussion regarding timely challenges in drug policy. This event included a discussion on new approaches and practical solutions to drug use, abuse, manufacture, and distribution facing the Trump Administration. Topics included advances in cannabis controls, racial bias in drug law enforcement, civil forfeiture, the ongoing opioid crisis, and new approaches to treating substance use disorders.

James M. Cole, Partner, Sidley Austin LLP and former U.S. Deputy Attorney General
Dr. Andrew Tatarsky, Founder and Director, The Center for Optimal Living
Allan Clear, Director, Office of Drug User Health, New York State Department of Health
Alyssa Aguilera, Co-Executive Director, VOCAL-NY
Tess Borden, 2015-2017 Aryeh Neier Fellow, American Civil Liberties Union and Human Rights Watch

Paul DeRienzo, Host, Let Them Talk on Manhattan Neighborhood Network

Sponsoring Association Committee:
Drugs & the Law Committee, Zarah Levin-Fragasso, Chair